Largest study confirms HPV vaccine protects against cervical cancer

Elections in the United States: Trump and Biden, in a new presidential debate with plexiglass and muted microphones

Nashville, the capital of country music in the state of Tennessee, is ready to host the second and last debate between the two candidates,...

Sweden is removing the interest rate recommendations for people over 70 years of age

The Swedish Public Health Authority said on Thursday that the recommendations for people aged 70 and over will be removed.Thus, older people no longer...

Chechen refugee who beheaded Samuel Paty is in contact with a Russian-speaking jihadist in Syria

The newspaper Le Parisien writes that this person was located with his IP address and was in Idlib - an unstable area in the...

Immediate imprisonment for the leaders of the ultra Golden Dawn party

He Athens Court of Appeal has decreed immediate prison for the Dome of the ultra greek party Golden Dawn, two weeks after the...

Belarusian opposition wins major European human rights prize

Belarusian opposition parties, united in the coordination council, received the European Parliament's Sakharov Prize on Thursday. The prize is a high European award...

Previous research has shown that vaccination can prevent HPV infection and the development of precancerous changes. It is reported that the effectiveness of a vaccine in the prevention of invasive cancer is so convincingly demonstrated by scientists for the first time.

Women who were vaccinated against HPV at a young age have a significantly lower risk of developing cervical cancer than those who are not vaccinated. Study published at New England Journal of Medicine.

What we knew about the effectiveness of the HPV vaccine

The most important goal of developing a vaccine and introducing immunization against human papillomavirus (HPV) was the prevention of infection with oncogenic HPV types and the prevention of the cervix. By the end of 2019, the national vaccination program approved 124 countries.

The media have repeatedly reported on the effectiveness of the vaccine. However, there have not been large studies previously conducted in which scientists have focused specifically on the incidence of cervical cancer. This is due to the fact that relatively little time has passed since the start of vaccination programs. Just one study concerned this question, but there were not enough participants to objectively assess the effect of the vaccine.

Mass HPV vaccination protects unvaccinated men from pharyngeal cancer

The prevalence of papillomavirus infection of the mouth and pharynx among unvaccinated men in the United States has decreased by 37%. Scientists believe that this was due to the emergence of population immunity due to the massive vaccination against the human papillomavirus (HPV).

Read the article

Previous studies have shown that HPV vaccination protects against HPV infection, genital warts, and precancerous changes cervix… These data spoke only indirectly that the vaccine can prevent invasive cancer. Invasive cancer called a malignant tumor that has gone beyond the tissues in which it formed and began to penetrate into neighboring healthy tissues. In this case, we are talking about cervical cancer, which has grown outside the mucous membrane.

What do we know about the effectiveness of the vaccine now

“We have been able to show for the first time at a population level that HPV vaccination protects not only against cellular changes that may be precursors of cancer, but also specifically against invasive cervical cancer.” said Jiayao Lei of the Karolinska Institute in Sweden, co-author of the study. He added that such an effect of the vaccine has long been suspected, but it has not been possible to confirm it in a large national study.

In the new study, researchers followed nearly 1.7 million women between the ages of 10 and 30 for 11 years. More than 500,000 of them received the HPV vaccine, most of them under the age of 17. During the study, cervical cancer developed in 19 vaccinated women and 538 unvaccinated women, which corresponds to 47 and 94 per 100 thousand, respectively.

After additional calculations, it turned out that women who were vaccinated before the age of 17 had an 88% lower risk of cervical cancer than those who did not receive the vaccine. In women vaccinated at the age of 17-30, this risk was 53% lower.

Scientists noted that the effectiveness of the vaccine in young girls is higher, most likely due to the fact that they were less likely to face HPV infection. Vaccination cannot protect after infection.

Overall, the new data support expectations about the value of HPV vaccination in preventing cervical cancer, the study authors said.



Coronavirus: 8 things we learned in recent months

Potential treatments that did not show benefit, airborne transmission, reinfections and prolonged symptoms, among others.SARS-CoV-2, the cause of the worst pandemic in the last...

Related Articles